Sponsor:
UCLA
Code:
NCT07250477
Conditions
Non-small Cell Lung Cancer Stage IIIC
Non-small Cell Lung Cancer Stage IV
Non Small Cell Lung Cancer
Non-small Cell Lung Cancer Metastatic
Non-small Cell Lung Cancer Unresectable
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Systemic (ICI)-based therapy informed by the PROphet CB assay and the CARG-TT assessment.
Standard of Care
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-10. This information was provided to ClinicalTrials.gov by University of California, Davis on 2026-02-09.